BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Formichi C, Fignani D, Nigi L, Grieco GE, Brusco N, Licata G, Sabato C, Ferretti E, Sebastiani G, Dotta F. Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study. Int J Mol Sci 2021;22:9454. [PMID: 34502360 DOI: 10.3390/ijms22179454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Conceição IMCAD, Luscher-dias T, Queiroz LR, de Melo AGB, Machado CR, Gomes KB, Souza RP, Luizon MR, Franco GR. Metformin Treatment Modulates Long Non-Coding RNA Isoforms Expression in Human Cells. ncRNA 2022;8:68. [DOI: 10.3390/ncrna8050068] [Reference Citation Analysis]
2 Grieco GE, Fignani D, Dotta F, Sebastiani G. MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future. L'Endocrinologo 2022. [DOI: 10.1007/s40619-022-01146-w] [Reference Citation Analysis]
3 Grieco GE, Besharat ZM, Licata G, Fignani D, Brusco N, Nigi L, Formichi C, Po A, Sabato C, Dardano A, Natali A, Dotta F, Sebastiani G, Ferretti E. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kraczkowska W, Stachowiak L, Pławski A, Jagodziński PP. Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences? J Appl Genet 2022. [PMID: 34984663 DOI: 10.1007/s13353-021-00678-5] [Reference Citation Analysis]